An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia

16503AALL2131-NCT06124157OpenAn International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia AALL2131NCT06124157NationalChildrenTreatmentIIINationalLymphoid LeukemiaPudela, CaileighPediatricsOncology GroupLombardi Comprehensive Cancer Center (LCCC)15940Richik ChakrabortyRichik Chakrabortyrc1586@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>